2 results match your criteria: "Norway. szilveszter.dolgos@rikshospitalet.no[Affiliation]"
Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation.
Scand J Clin Lab Invest
May 2009
Medical Center, Rikshospitalet-Radiumhospitalet, University of Oslo, Oslo, Norway.
Background: Serum osteocalcin and C-terminal telopeptides of type-1 collagen (CTX-1) are known markers of bone turnover, whereas the role of fibroblast growth factor 23 (FGF-23) is yet unknown. We investigated early changes in bone mass and the association of these biochemical markers and FGF-23 with bone loss following renal transplantation (RTx).
Material And Methods: In 44 first-kidney allograft patients, BMD was measured by dual-energy X-ray absorptiometry in the lumbar spine (LS), total femur (TF) and total body (TB) at baseline and 10 weeks post-transplant.
Determinants of short-term changes in body composition following renal transplantation.
Scand J Urol Nephrol
March 2009
Medical Department, Section of Nephrology and Laboratory for Renal Physiology, Rikshospitalet, Oslo, Norway.
Objective: Changes in body composition after renal transplantation (RTx) are of clinical significance, since increments in fat mass may contribute to glucose intolerance and cardiovascular morbidity. The aim of this study was to quantify the early changes in body composition after transplantation and identify predictors of these changes.
Material And Methods: Total and regional body composition of 102 first kidney allograft recipients were measured at transplantation and after 10 weeks using dual-energy X-ray absorptiometry.